VistaGen Therapeutics Inc. | Balance Sheet
Fiscal year is April-March. All values USD Thousands.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
-
70.00
428.50
2,921.30
10,378.30
13,100.30
Total Accounts Receivable
2.80
-
-
-
-
300
Other Current Assets
37.70
35.70
426.80
456.60
644.80
250.90
Total Current Assets
40.50
105.70
855.30
3,377.90
11,023.10
13,651.20
Net Property, Plant & Equipment
176.30
117.10
87.60
286.50
207.40
312.70
Long-Term Note Receivable
198.10
-
-
-
-
-
Other Assets
46.90
46.90
46.90
47.80
47.80
47.80
Total Assets
461.80
269.70
989.80
3,712.20
11,278.30
14,011.70
ST Debt & Current Portion LT Debt
1,893.80
11,754.90
32.70
57.20
56.50
Accounts Payable
2,443.90
-
-
867.30
1,195.70
Other Current Liabilities
868.00
5,633.20
1,762.00
443.00
206.30
Total Current Liabilities
5,205.70
17,388.10
1,794.70
1,367.50
1,458.50
Long-Term Debt
3,920.40
286.70
27.20
11.90
9.30
Other Liabilities
3,937.50
3,137.70
2,145.10
1,717.00
2,893.90
Total Liabilities
13,063.60
20,812.50
3,967.00
3,096.40
4,361.70
Common Equity (Total)
12,602.30
20,543.30
2,983.70
611.80
6,912.60
Total Shareholders' Equity
12,601.80
20,542.80
2,977.20
615.80
6,916.60
Total Equity
12,601.80
20,542.80
2,977.20
615.80
6,916.60
Liabilities & Shareholders' Equity
461.80
269.70
989.80
3,712.20
11,278.30
Preferred Stock (Carrying Value)
0.50
0.50
6.50
4.00
4.00
About VistaGen Therapeutics
View Profile
